 Summary of this article
- CDSCO investigation uncovers TNFDA regulatory lapses in monitoring Sresan Pharma.
- Coldrif cough syrup contained 48% diethylene glycol, far exceeding safety limits.
- Union Health Secretary urges stricter compliance and rational use of paediatric cough syrups.
The investigation into the Kanchipuram-based manufacturer of Coldrif cough syrup, linked to the deaths of children in Madhya Pradesh, has exposed serious lapses by the Tamil Nadu Food and Drug Administration (TNFDA) in enforcing regulatory norms, according to sources from the Central Drugs Standard Control Organisation (CDSCO).
Licensed in 2011, Sresan Pharmaceutical continued operations for over a decade despite inadequate infrastructure and repeated violations of national drug safety rules. A recent CDSCO inspection revealed the unit’s complete non-compliance with Good Manufacturing Practices (GMP).
According to PTI, the CDSCO was not involved in prior audits, and the TNFDA did not share any information about the company, leaving Sresan Pharma unlisted in CDSCO databases. Rule 84AB of the Drugs and Cosmetics Rules, which requires manufacturers to update approved products on the ‘Sugam’ portal to aid national monitoring, was also not complied with by the company.
Sources told PTI that despite a 2023 CDSCO initiative to create a centralised database, which included communications and reminders to the TNFDA and manufacturers, Sresan Pharma neither registered its products nor did the state FDA facilitate the process.
[url=]Related Content[/url]
 Madhya Pradesh Government Doctors Protest ‘Illegal Arrest’ In Cough Syrup Deaths Case
Madhya Pradesh: Two More Children Die After Consuming 'Contaminated' Cough Syrup; Death Toll Rises to 22
Madhya Pradesh Forms SIT To Investigate Deaths Of 14 Children Linked to Contaminated Cough Syrup
 Doctor In Madhya Pradesh Arrested For Prescribing Coldrif Cough Syrup That Killed 14 Children
[url=]Related Content[/url]
Madhya Pradesh Government Doctors Protest ‘Illegal Arrest’ In Cough Syrup Deaths Case
Madhya Pradesh: Two More Children Die After Consuming 'Contaminated' Cough Syrup; Death Toll Rises to 22
Madhya Pradesh Forms SIT To Investigate Deaths Of 14 Children Linked to Contaminated Cough Syrup
Doctor In Madhya Pradesh Arrested For Prescribing Coldrif Cough Syrup That Killed 14 Children
The TNFDA conducted an audit of Sresan Pharma on October 1-2 at the request of Madhya Pradesh authorities but did not inform CDSCO headquarters or zonal offices. During a joint risk-based inspection by CDSCO on October 3, the TNFDA did not participate despite multiple requests. CDSCO subsequently recommended cancellation of the company’s manufacturing licence.
PTI reported that TNFDA also delayed sharing the analysis of Coldrif cough syrup, which revealed 48 per cent diethylene glycol (DEG)—far above the permissible limit of 0.1 per cent—creating confusion between TNFDA, MPFDA, and CDSCO. |
